Jim Simons’s Sanara MedTech SMTI Stock Holding History

Jim Simons’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.11M	Buy	64,680 +27,078	+72%	+$557K	﹤0.01%	2221
2025 Q4	$878K	Sell	37,602 -4,098	-10%	-$106K	﹤0.01%	2349
2025 Q3	$1.32M	Buy	41,700 +4,300	+11%	+$130K	﹤0.01%	2338
2025 Q2	$1.06M	Buy	37,400 +3,100	+9%	+$93K	﹤0.01%	2489
2025 Q1	$1.06M	Sell	34,300 -1,100	-3%	-$37.3K	﹤0.01%	2390
2024 Q4	$1.18M	Buy	35,400 +21,400	+153%	+$726K	﹤0.01%	2402
2024 Q3	$423K	Sell	14,000 -100	-0.7%	-$3.12K	﹤0.01%	2858
2024 Q2	$398K	Sell	14,100 -800	-5%	-$25.1K	﹤0.01%	2794
2024 Q1	$551K	Buy	14,900 +4,900	+49%	+$183K	﹤0.01%	2820
2023 Q4	$411K	Buy	10,000 +1,200	+14%	+$38.5K	﹤0.01%	2859
2023 Q3	$274K	Buy	+8,800	New	+$341K	﹤0.01%	2973
2021 Q3	–	Sell	-7,300	Closed	-$270K	–	3812
2021 Q2	$270K	Buy	+7,300	New	+$213K	﹤0.01%	3177

Other funds holding SMTI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SWM

Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Jim Simons's SMTI Position: Q1 2026 in Review

Jim Simons increased its Sanara MedTech (SMTI) stake by 72% in Q1 2026, buying an estimated $557K and bringing the position to 64,680 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #2221.

Jim Simons first reported a position in SMTI in Q2 2021 and has held it in 12 quarters since. The position peaked at $1.32M in Q3 2025. 65 funds tracked by Wall St. Rank hold SMTI as of Q1 2026.

Jim Simons held 64,680 shares of Sanara MedTech worth $1.11M as of Q1 2026.
Jim Simons bought 27,078 Sanara MedTech shares in Q1 2026, an estimated $557K.
Sanara MedTech made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #2221 holding.
Jim Simons first reported a position in Sanara MedTech in Q2 2021 and has held it in 12 quarters since.
Jim Simons's Sanara MedTech position peaked at $1.32M in Q3 2025.
65 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.